Sign in

CIK 0001540171 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Avalyn Pharma Inc.

Sign in to watch
Ticker
AVLN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452463191
Phone
(206) 707-0340
Business address
105 W FIRST ST., BOSTON, MA, 02127
Former names
Genoa Pharmaceuticals, Inc.
  1. 4 Open-market sale 10% owner sold 228,454 shares at an average $29.33 ($6,701,004)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Executive or director change
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Material agreement
  13. 8-K Event Regulation FD disclosure
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SCHEDULE 13D Stake Beneficial Ownership Report
  17. SCHEDULE 13D Stake Beneficial Ownership Report
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 4 Insider Changes in Ownership
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 1 of 4 · 66 filings